Clinical Trial Update: A Dosing Study of Hyperbaric Oxygen Therapy (HBOT) on Epigenetic Aging [Phase 2, Phase 3]

View source ↗

Summary

A dosing study of hyperbaric oxygen therapy on epigenetic aging is reported as a Phase 2/Phase 3 trial with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging

Drugs mentioned

• Hyperbaric Oxygen Therapy

Snippet

Sponsor: TruDiagnostic | Conditions: Aging | Phase 2, Phase 3 | Status: UNKNOWN